##semicolon##
юрак ишемик касаллиги, 2-тур қандли диабет, стентлаш, клопидогрел, зугрел, гемодинамика, коагуляция, иммунологик кўрсаткичлар.##submission.citations##
American Diabetes Association. (2023). Standards of Medical Care in Diabetes—2023. Diabetes Care, 46(Suppl. 1), S1–S154.
A.T. Akhmedov (2024). Impact of cytokines on the onset and progression of arterial hypertension. Eurasian Journal of Medical and Natural Scien-ces, 4 (6), 116-123. doi: 10.5281/zenodo.12154505.
Akhmedov, A. T., & Sharipov, Z. R. (2023). The role of cytokines in the development of arterial hypertension. Int J Med Sci Clin Res, 3(03), 59-67.
Matsushita, K., & Coresh, J. (2020). Diabetes, CKD, and cardiovascular disease. Journal of the American Society of Nephrology, 31(2), 236–245.
Ridker, P. M., Everett, B. M., Thuren, T., et al. (2017). Antiinflammatory therapy with canaki-numab for atherosclerotic disease. New England Journal of Medicine, 377(12), 1119–1131.
Roth, G. A., Mensah, G. A., Johnson, C. O., et al. (2020). Global burden of cardiovascular diseases and risk factors, 1990–2019. Journal of the American College of Cardiology, 76(25), 2982–3021.
Schramm, T. K., Gislason, G. H., Køber, L., et al. (2019). Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk. Circulation, 117(15), 1945–1954.
Seferović, P. M., Petrie, M. C., Filippatos, G. S., et al. (2018). Type 2 diabetes mellitus and heart failure: a position statement from the Heart Failure Association. European Journal of Heart Failure, 20 (5), 853–872.
Wiviott, S. D., Braunwald, E., McCabe, C. H., et al. (2007). Prasugrel versus clopidogrel in patients with acute coronary syndromes. New England Journal of Medicine, 357(20), 2001–2015.
World Health Organization. (2023). Cardiovascular diseases (CVDs). Retrieved from https:// www.who.int